Quantitative Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking the Antipsychotic Medications Fanapt (Iloperidone) or Zyprexa (Olanzapine) or Placebo
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Iloperidone (Primary) ; Olanzapine
- Indications Psychotic disorders
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 25 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Aug 2014 Planned End Date changed from 1 Jun 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.